Recent Finacing
Recent Raise
Navigator Medicines develops biologics to modulate immune function for complex autoimmune diseases, advancing NAV-240, a bispecific OX40L/TNFα antibody, and other clinical-stage programs from its Scotch Plains, NJ base.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Navigator Medicines.
